NCT07391423Not yet recruiting
Assessing Psoriasis Treatment Outcomes
Assessing Psoriasis Treatment Outcomes: a Single-center, Prospective Study Evaluating Patient Outcomes in Psoriasis
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 21 Jan 2026
- Start date
- Oct 2026
- Primary completion date
- Dec 2028
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Psoriasis
- NCT number
- NCT07391423
What you commit to
- Study type: Interventional
- Planned participants: 15
- From Oct 2026 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients that are taking concomitant topical or systemic therapy for the treatment of psoriasis and/or phototherapy
- Patients without a current diagnosis of psoriasis suitable for treatment with topical BD
Other illness
- Patients with severe or unstable comorbid conditions
- Patients with any other skin conditions that prohibit or confound the ability of the investigator to interpret skin findings
Age
- Patients less than the age of 18
Other
- Patient who are pregnant or breastfeeding
- Patients without mobile devices able to at least operate at 25 frames per second (FPS).
Who the study is looking for
- Patients ≥18 years of age
- Patients with a current diagnosis of psoriasis suitable for treatment with topical Betamethasone (BD)
- Patients who live in the United States
- Patients with a sufficient command of the English language
- Patients with a mobile device able to at least operate at 25 frames per second (FPS).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wake Forest University Health Sciences Department of Dermatology Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.